Abbott Laboratories (NYSE:ABT) is one of the Best Conservative Stocks to Buy Right Now. On March 23, the company announced that it had completed the acquisition of Exact Sciences. As a result of this, ...

The deal brings Exact Sciences' flagship screening test for colorectal cancer, Cologuard, under Abbott's umbrella.

An ex- Abbott Laboratories Inc. subsidiary sales manager is bound by Minnesota law and doesn’t qualify as an employee to sue ...

This article examines whether Abbott Laboratories, at around US$104 a share, is starting to look interesting or still pricing ...

A federal appeals court has ruled that a remote employee who reported alleged anti-kickback violations fell outside the reach ...

Abbott Laboratories (NYSE:ABT) ranks among the best most active stocks to buy right now. Following encouraging results from ...

Monday - Friday, 6:00 - 7:00 PM ET CNBC's Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that's been weighed down by ongoing litigation for several months.

Abbott closes $21B acquisition of Exact Sciences (EXAS) at $105/share. EXAS delisted from Nasdaq on March 23, 2026, becoming ...

Add Yahoo as a preferred source to see more of our stories on Google. A federal judge has thrown out a second case against Abbott Laboratories over the safety of its formula for babies born ...

Abbott Laboratories will invest $40 million over five years into its highly-scrutinized Michigan plant to resolve stockholder ...

Shares of Abbott Laboratories ABT slipped 1.61% to $105.46 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 1.51% to 6,506.48 ...

The outlook and technical action suggest Abbott Laboratories (NYSE: ABT) will lead healthcare names like Johnson & Johnson (NYSE: JNJ) higher in 2025. While each produced a solid quarter, Abbott ...